Blockchain Registration Transaction Record
Clinilabs Strengthens Leadership Team to Drive CNS Innovation
Clinilabs enhances its leadership with David Hagerman as CFO and Jeanine Falinski as SVP of Commercial Development, aiming to advance CNS drug and tech development.

The strategic appointments at Clinilabs signal a robust phase of growth and innovation in CNS drug and technology development. For stakeholders in the healthcare and pharmaceutical industries, this move underscores the increasing importance of specialized expertise in addressing complex CNS disorders. Patients and healthcare providers stand to benefit from accelerated development and approval of new therapies, potentially improving outcomes for those affected by psychiatric, neurological, and substance use disorders.
Blockchain | Details |
---|---|
Contract Address | 0xeA2912a8DA1CD48401b10cB283585874d98098F4 |
Transaction ID | 0x5b8ca9d2efab9b65b23f40de1de503b06b3e927a2a72bc8cf8bab66ed883effc |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | paleMWJg-4f50040ea67c6231bd90cee85951dfdf |